Details for New Drug Application (NDA): 062560
NDA 062560 describes MANDOL, which is a drug marketed by Lilly and is included in two NDAs. Additional details are available on the MANDOL profile page.
The generic ingredient in MANDOL is cefamandole nafate. There is one drug master file entry for this compound. Additional details are available on the cefamandole nafate profile page.
The generic ingredient in MANDOL is cefamandole nafate. There is one drug master file entry for this compound. Additional details are available on the cefamandole nafate profile page.
Summary for 062560
| Tradename: | MANDOL |
| Applicant: | Lilly |
| Ingredient: | cefamandole nafate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062560
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Sep 10, 1985 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Sep 10, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
